PAVM compared with SYK: revenue, margins and what each company keeps, and the suppliers and customers both name

PAVMPAVmed Inc.

Mkt capRevenueRevenue

SYKStryker Corp

Mkt capRevenueRevenue

Compare

PAVMPAVmed Inc.

SYKStryker Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PAVM

Reportimpliedrealized× implied

Q2 FY26—▲+9.70%—

May 15 '26—▲+1.24%—

Q1 FY26—▲+13.03%—

Q3 FY25—▼−8.49%—

SYK

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.2%▼−6.38%×0.89

Q2 FY26±6.5%▼−6.42%×0.98

= impliedPAVM realized, solidSYK realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.8%

▼−6.47%

×1.12

Jan 30 '26±5.2%▲+4.31%×0.83

PAVMPAVmed Inc.

1.57▲+1.29%· post 1.62

Mkt cap$12.6MRevenue$33,000Q2 FY26Revenue$71,000FY25

SYKStryker Corp

325.40▼−2.89%· post 325.87

ClosedNov 6 '26

Mkt cap$124.1BRevenue$6.5BQ3 FY26Revenue$25.1BFY25

Compare

ClosedNov 6 '26

PAVMPAVmed Inc.

SYKStryker Corp

1.57▲+1.29%post 1.62

Price

325.40▼−2.89%post 325.87

$12.6M

Mkt cap

$124.1B

Q2 FY26$33,000

Revenue

$6.5BQ3 FY26

FY25$71,000

Revenue

$25.1BFY25

PAVM1.57▲+1.29%vsSYK325.40▼−2.89%ClosedNov 6 '26